PEAK PHARMACEUTICALS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
PEAK PHARMACEUTICALS, INC. (RMHI) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 163.66 thousand shares for the 3-month period ending 2022-12-31, per its 10-Q filed 2023-02-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2023-02-09
- PEAK PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2022-12-31 was 163.66K shares, a 39.82% decline year-over-year.
- PEAK PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2021-12-31 was 271.94K shares, a 40.06% decline year-over-year.
- PEAK PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2020-12-31 was 453.64K shares, a 82.06% decline year-over-year.
- PEAK PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2019-12-31 was 2.53M shares, a 897.00% increase year-over-year.
- PEAK PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 327.32K shares, a 5.18% increase from fiscal 2021.
- PEAK PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2021 was 311.21K shares, a 89.83% decline from fiscal 2020.
- PEAK PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2020 was 3.06M shares, a 11.41% increase from fiscal 2019.
- PEAK PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2019 was 2.75M shares, a 1061.04% increase from fiscal 2018.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2022-12-31 | 163.66K shares 10-Q · filed 2023-02-09 | |||
| 2022-09-30 | 327.32K shares 10-K · filed 2022-12-19 | |||
| 2022-06-30 | 348.48K shares 10-Q · filed 2022-12-19 | |||
| 2022-03-31 | 282.20K shares 10-Q · filed 2022-12-19 | |||
| 2021-12-31 | 271.94K shares 10-Q · filed 2023-02-09 | |||
| 2021-09-30 | 311.21K shares 10-K · filed 2022-12-19 | |||
| 2021-06-30 | 339.16K shares 10-Q · filed 2022-12-19 | |||
| 2021-03-31 | 275.55K shares 10-Q · filed 2022-12-19 | |||
| 2020-12-31 | 453.64K shares 10-Q · filed 2022-12-19 | |||
| 2020-09-30 | 3.06M shares 10-K · filed 2022-12-19 | |||
| 2020-06-30 | 2.43M shares 10-Q · filed 2022-12-19 | |||
| 2020-03-31 | 2.47M shares 10-Q · filed 2022-12-19 | |||
| 2019-12-31 | 2.53M shares 10-Q · filed 2022-12-19 | |||
| 2019-09-30 | 2.75M shares 10-K · filed 2022-12-19 | |||
| 2019-06-30 | 871.98K shares 10-Q · filed 2022-12-19 | |||
| 2019-03-31 | 334.05K shares 10-Q · filed 2022-12-19 | |||
| 2018-12-31 | 253.69K shares 10-Q · filed 2022-12-19 | |||
| 2018-09-30 | 236.48K shares 10-K · filed 2022-12-19 | |||
| 2018-06-30 | 199.88K shares 10-Q · filed 2022-12-19 | |||
| 2018-03-31 | 317.01K shares 10-Q · filed 2022-12-19 | |||
| 2017-12-31 | 182.03K shares 10-Q · filed 2022-12-19 | |||
| 2017-09-30 | 903.07K shares 10-K · filed 2022-12-19 |